Cargando…

RWD26 Real World Evidence for the Impact of COVID-19 Pandemic on the Incidence of Multiple Myeloma in Germany

Detalles Bibliográficos
Autores principales:	Schilling, S, Azarias, G, Merker, L, Strobel, K, Wischlen, S, Kellermann, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232833/ http://dx.doi.org/10.1016/j.jval.2022.04.1550

Ejemplares similares

RWD156 The Impact of the Sars-Cov-2 Pandemic (COVID-19) on the Incidence of Newly Diagnosed Multiple Myeloma Patients Using a Federated Network of Real-World Evidence in US and Germany
por: Schilling, S., et al.
Publicado: (2023)

RWD-derived response in multiple myeloma
por: Xu, Tao, et al.
Publicado: (2023)

Editorial: Real world evidence, outcome research and healthcare management improvement through real world data (RWD)
por: Varela-Rodríguez, Carolina, et al.
Publicado: (2023)

RWD-Cockpit: Application for Quality Assessment of Real-world Data
por: Babrak, Lmar Marie, et al.
Publicado: (2022)

RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD)
por: Kolbin, A, et al.
Publicado: (2022)

Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study
por: Pericay, Carles, et al.
Publicado: (2023)

Diagnostic and therapeutic approaches to multiple myeloma patients: ‘Real-world’ data from representative multicentre treatment surveys in Germany between 2008 and 2011
por: Moehler, Thomas M., et al.
Publicado: (2016)

P948: REAL-WORLD EVIDENCE OF BISPHOSPHONATES FOR MULTIPLE MYELOMA
por: Muñoz, Maria Nieves Lopez, et al.
Publicado: (2023)

P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB
por: Marschner, N., et al.
Publicado: (2022)

Research ethics with real-world data (RWD) on COVID-19 infections: the unCoVer study: Silvia Riva
por: Riva, S, et al.
Publicado: (2022)

RWD164 The Impact of the COVID-19 Pandemic on Patients With Type 2 Diabetes in Greece: Results From a Real-World Study
por: Daflla, L-, et al.
Publicado: (2022)

P958: REAL-WORLD TREATMENT PATTERNS IN PATIENTS INITIATING THIRD-LINE THERAPY FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN GERMANY, ITALY, THE UK, FRANCE, AND SPAIN
por: Ramasamy, Karthik, et al.
Publicado: (2023)

RWD152 Real-World Evidence on the Use of Ecmo in Hospitalized COVID-19 Patients: Results from a Linked Closed and Open Claims Database in the US
por: Kuranz, S., et al.
Publicado: (2023)

Multiple myeloma: patient outcomes in real‐world practice
por: Yong, Kwee, et al.
Publicado: (2016)

Real‐world treatment patterns and outcomes in non‐transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom
por: Mohty, Mohamad, et al.
Publicado: (2020)

Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
por: Stork, Martin, et al.
Publicado: (2023)

The real-world outcomes of multiple myeloma patients treated with daratumumab
por: Szabo, Agoston Gyula, et al.
Publicado: (2021)

1594P SARS-CoV-2 vaccines in cancer patients (pts), real-world data (RWD) from 1069 Belong.life users
por: Sapir, E., et al.
Publicado: (2021)

RWD91 A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine
por: Kolbin, A, et al.
Publicado: (2022)

RWD95 Exploring the Burden of COVID-19 on Suicides and Suicidal Attempts (SSA) in Pre- and During-COVID-19 Pandemic Using Real-World Data
por: Gaur, A, et al.
Publicado: (2022)

RWD57 Epidemiological Study of the Burden of COVID-19 on Depression in Men (DIM) in Pre- and During COVID-19 Pandemic Using Real-World Data
por: Sharma, A, et al.
Publicado: (2022)

Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma
por: Lecat, Catherine S. Y., et al.
Publicado: (2021)

Ten-Year Outcomes Of Intensity-Modulated Radiotherapy (IMRT) Combine With Chemotherapy Versus IMRT Alone For Stage II Nasopharyngeal Carcinoma In The Real-World Study (RWD)
por: Ding, Xing-Chen, et al.
Publicado: (2019)

Implementation of a data control framework to ensure confidentiality, integrity, and availability of high-quality real-world data (RWD) in the NeuroTransData (NTD) registry
por: Wehrle, Knut, et al.
Publicado: (2022)

RWD128 Exploring the Burden of COVID-19 on Post-Traumatic Stress Disorder (PTSD) in Pre- and During-COVID-19 Pandemic Using Real-World Data
por: Kukreja, I, et al.
Publicado: (2022)

The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
por: Turner, Rose, et al.
Publicado: (2022)

The Incidence and Timing of Blood Cultures in Multiple Myeloma – Results from a Retrospective, Single Center, Real-World Study
por: Szabo, Agoston Gyula, et al.
Publicado: (2020)

RWD70 Impact of COVID-19 on the Utilization of Behavioral Healthcare Services in the US
por: Kukreja, I, et al.
Publicado: (2022)

RWD60 Exploring the Burden of COVID-19 on Eating Disorders Spectrum (Types of Eating Disorders) in Pre- and During-COVID-19 Pandemic Using Real-World Data
por: Verma, V, et al.
Publicado: (2022)

RWD111 Influenza Vaccine Sales During the COVID-19 Era
por: Ngami, A, et al.
Publicado: (2022)

RWD68 Characteristics/Comorbidities of Vaccinated and Unvaccinated Patients With COVID-19
por: Roy, A, et al.
Publicado: (2022)

RWD67 Association of COVID-19 With Venous Thrombosis and Arterial Thrombosis
por: Pandey, S, et al.
Publicado: (2022)

Bortezomib retreatment for relapsed and refractory multiple myeloma in real‐world clinical practice
por: Hulin, Cyrille, et al.
Publicado: (2018)

Real World Multiple Myeloma Registry from Jordan, a Developing Country
por: Qasem, Farah, et al.
Publicado: (2022)

Real-world renal function among patients with multiple myeloma in the United States
por: Mikhael, Joseph, et al.
Publicado: (2021)

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma
por: Orlowski, Robert Z.
Publicado: (2018)

RWD31 Comparison of Remdesivir As Monotherapy or in Combination with Steroids in Treating COVID-19 Patients
por: Rawat, M, et al.
Publicado: (2022)

Real-world effectiveness of osteoporosis treatments in Germany
por: O’Kelly, James, et al.
Publicado: (2022)

Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
por: Macro, M., et al.
Publicado: (2023)

Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data
por: Kim, Christopher, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_olh1cu9hko3b6af2jlsp0gtrii